Literature DB >> 29758293

TLE1, a key player in neurogenesis, a new candidate gene for autosomal recessive postnatal microcephaly.

Mara Cavallin1, Camille Maillard2, Marie Hully3, Marion Philbert2, Nathalie Boddaert4, Madeline Louise Reilly5, Patrick Nitschké6, Amandine Bery7, Nadia Bahi-Buisson8.   

Abstract

Postnatal microcephaly comprises a heterogeneous group of neurodevelopmental disorders of varying severity, characterized by normal head size at birth, followed by a postnatal deceleration in head circumference of greater than 3 standard deviations (SD) below the mean. Many postnatal microcephaly syndromes are caused by mutations in genes known to be important for the regulation of gene expression in the developing forebrain. We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation. Using trio-based exome sequencing, we identified a homozygous missense mutation in the Transducin-like enhancer of split-1 (TLE1) gene, encoding for a non DNA-binding transcriptional corepressor, highly expressed in the postnatal brain. The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome. Functional analysis on affected dermal fibroblasts showed a significant decrease in mitotic and proliferative index, indicating a lengthening of the cell cycle and a delay in mitosis, supporting that this gene could be a new candidate for postnatal microcephaly.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cortical malformation; Postnatal microcephaly; TLE1

Mesh:

Substances:

Year:  2018        PMID: 29758293     DOI: 10.1016/j.ejmg.2018.05.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors in vitro and Predicts a Better Prognosis in Pancreatic Ductal Adenocarcinoma.

Authors:  Yizhi Wang; Da Yuan; Li Zhou; Zhiyong Liang; Weixun Zhou; Jun Lu; Bolun Jiang; Lei You; Junchao Guo; Yu-Pei Zhao
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

2.  Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development.

Authors:  Elena Perenthaler; Soheil Yousefi; Eva Niggl; Tahsin Stefan Barakat
Journal:  Front Cell Neurosci       Date:  2019-07-31       Impact factor: 5.505

3.  Abnormal cranium development in children and adolescents affected by syndromes or diseases associated with neurodysfunction.

Authors:  Agnieszka Guzik; Lidia Perenc; Mariusz Drużbicki; Justyna Podgórska-Bednarz
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

4.  TLE2 is associated with favorable prognosis and regulates cell growth and gemcitabine sensitivity in pancreatic cancer.

Authors:  Shixiong Hu; Zhengbo Chen; Jinling Gu; Liyang Tan; Meifeng Zhang; Weidong Lin
Journal:  Ann Transl Med       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.